Clinical Trials
Closed
Phase
SWOG Clinical Trial Number
SWOG-8854
Closed
Phase
Accrual
36%
Published
SWOG Clinical Trial Number
SWOG-8812
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8814
Phase lll Comparison of Adjuvant Chemoendocrine Therapy with CAF and Concurrent or Delayed Tamoxifen to Tamoxifen Alone in Postmenopausal Patients with Involved Axillary Lymph Nodes and Positive Receptors (Intergroup)
Research Committee(s)
Breast Cancer
Activated
05-15-1989
Closed
08-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8900
A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma
Activated
05-01-1989
Closed
12-01-1991
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-8822
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma
Activated
05-01-1989
Closed
06-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8824
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma
Activated
05-01-1989
Closed
08-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8708
Treatment of Hormonally Refractory Stage D Carcinoma of the Prostate with CHIP
Activated
04-01-1989
Closed
09-01-1990
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
SWOG-8830
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer
Activated
04-01-1989
Closed
11-15-1990
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-8832
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer
Activated
04-01-1989
Closed
11-15-1990
Closed
Phase
Accrual
14%
SWOG Clinical Trial Number
SWOG-8823
Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL2) in Patients with Colorectal Carcinoma
Activated
04-01-1989
Closed
11-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8836
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
SWOG-8829
Evaluation of Amonafide in the Treatment of CNS Tumors
Activated
03-15-1989
Closed
12-01-1990
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
SWOG-8791 (INT-0087)
Adjuvant Trial of Soft Tissue Sarcomas
Activated
03-01-1989
Closed
12-01-1990
Closed
Phase
Accrual
17%
SWOG Clinical Trial Number
SWOG-8820
Fluorouracil/Leucovorin and Embolization in the Treatment of Duke's D Colon Cancer, Phase II Pilot
Activated
03-01-1989
Closed
06-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8852
Accelerated Fractionation Radiation Therapy and Cisplatin in Patients With Advanced and Unresectable Squamous Cell Carcinoma of the Head and Neck
Activated
03-01-1989
Closed
08-01-1992
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8819
Central Lymphoma Repository Tissue Procurement Protocol
Research Committee(s)
Lymphoma
Molecular Epidemiology
Activated
02-15-1989
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8802
Evaluation of Echinomycin in Renal Cell Carcinoma
Activated
01-15-1989
Closed
07-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8754
Evaluation of Didemnin B in Disseminated Malignant Melanoma
Activated
01-15-1989
Closed
05-01-1990
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-8825
Phase I Trial of Intravenous Bolus Melphalan With GM-CSF
Activated
12-15-1988
Closed
12-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8725
Evaluation of Amonafide in Cervical Cancer
Activated
12-01-1988
Closed
12-01-1990